Friday, August 1, 2025

Latest

Oncology Firm TransCode Therapeutics Looks To Raise US$25 Million In IPO

Oncology company TransCode Therapeutics, Inc. is set to begin publicly trading its equityon the Nasdaq Capital Market today under the symbol “RNAZ.” The company is looking to raise an aggregate sum of US$25.0 million in its initial public offering.

The offering will consist of 6,250,000 common shares priced at US$4.00 per share. The underwriters were also granted a 45-day over-allotment option to purchase an additional 937,500 common shares at the same offering price, bringing the possible proceeds of the offering to US$28.8 million.

In its statement, TransCode refers to itself as an RNA oncology company centered on the belief that cancer can be addressed through RNA therapeutics. Proceeds from the offering will be intended to progress the trial and develop its therapeutic candidate, TTX-MC138, which is focused on treating metastatic cancer.

The offering is expected to close on July 13, 2021, subject to customary closing conditions. Fordham Financial division ThinkEquity acts as the sole underwriter for the offering.


Information for this briefing was found via Sedar and TransCode. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Gold’s Bull Run May Just Be Getting Started! | Peter Grandich

Tariffs Spark New Race for Critical Metals | Rob McEwen

Antimony Resources: The Bald Hill Project

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Nvidia Props Up Customer CoreWeave’s IPO

Nvidia will reportedly anchor the much-anticipated initial public offering of CoreWeave at $40 per share...

Sunday, March 30, 2025, 09:32:00 AM

Restaurant Operator Yoshiharu Prices Upsized US$11.8 Million IPO

Restaurant operator Yoshiharu Global Co. (Nasdaq: YOSH) started trading on the Nasdaq Capital Market on...

Friday, September 9, 2022, 02:22:00 PM

SPAC Welsbach Technology Metals Acquisition Prices US$75 Million IPO

Special purpose acquisition company Welsbach Technology Metals Acquisition Corp. (Nasdaq: WTMAU) started trading publicly on...

Wednesday, December 29, 2021, 02:18:00 PM

It’s Been A Painful Year For IPOs, Proceeds Are Down 93%

It hasn’t been a good year for companies going public  — uncertainty from mounting recession...

Monday, December 5, 2022, 03:06:00 PM

Electric Vehicle Maker Phoenix Motorcars Bats For Nasdaq IPO

Phoenix Motor Inc. is looking to join the list of electric vehicle manufacturers going public....

Monday, November 29, 2021, 02:10:00 PM